// App-Quantinova.ai

2692130 : BEST1 gene augmentation therapy corrects light-modulated retinal micro-detachments

Researchers

Presenter

  • Karina E Guziewicz

Principal Investigators

  • Artur V Cideciyan

  • William A Beltran

  • Andras M Komaromy

  • Valerie Dufour

  • Malgorzata Swider

  • Simone Iwabe

  • Alexander Sumaroka

  • Brian T Kendrick

  • Gordon Ruthel

  • Vince A Chiodo

  • Elise Heon

  • William W Hauswirth

  • Samuel G Jacobson

  • Gustavo D Aguirre

Medical Centers

  • Department of Small Animal Clinical Sciences, Michigan State University, East Lansing, Michigan, United States

  • Department of Bioengineering, University of Pennsylvania, Philladelphia, Pennsylvania, United States

  • Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada

  • Gastroenterology, University of Florida, Gainesville, Florida, United States

  • Department of Bioengineering, University of Pennsylvania, Philladelphia, Pennsylvania, United States

  • Department of Clinical Sciences and Advanced Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Ophthalmology (OP)

Disease

  • N/A

Biomarkers

  • Bestrophin1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved